Chemoimmunotherapy for cutaneous melanoma with dacarbazine and epifocal contact sensitizers: Results of a nationwide survey of the German Dermatologic Co-operative Oncology Group

P. Terheyden^*, A. K. Kortüm, H. J. Schulze, B. Durani, R. Remling, C. Mauch, V. Junghans, D. Schadendorf, U. Beiteke, M. Jünger, J. C. Becker, E. B. Bröcker

^*Corresponding author for this work